Clinical Trial Update: Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of mycophenolate mofetil on surrogate markers of cardiovascular disease in HIV-1 infected patients with atheroscle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• HIV Infection

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: HIV Infection, Atherosclerosis | Phase 4 | Status: UNKNOWN